4//SEC Filing
Gline Matthew 4
Accession 0001140361-25-035435
CIK 0001635088other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 7:28 PM ET
Size
4.9 KB
Accession
0001140361-25-035435
Insider Transaction Report
Form 4
Gline Matthew
DirectorCEO
Transactions
- Purchase
Common Shares
2025-09-18$15.07/sh+3,315$49,957→ 17,287,081 total
Footnotes (1)
- [F1]The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares purchased at each separate price within the range.
Documents
Issuer
Roivant Sciences Ltd.
CIK 0001635088
Entity typeother
Related Parties
1- filerCIK 0001750094
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 7:28 PM ET
- Size
- 4.9 KB